MyAverix Finance
TWO · Healthcare
Excelsior Biopharma (6496)
Drug Manufacturers - Specialty & Generic
Excelsior Biopharma (6496) is listed on TWO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $1.36B, P/E ratio is 18.00, net margin is -19.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 6496
Excelsior Biopharma (6496) — FAQ
What is Excelsior Biopharma's market cap?
Excelsior Biopharma (6496) has a reported market cap of $1.36B (data as of 2026-03-29).
What is 6496's P/E ratio?
The price-to-earnings (P/E) ratio for Excelsior Biopharma (6496) is 18.00 (data as of 2026-03-29).
Does Excelsior Biopharma pay a dividend?
Dividend yield is not available in the current snapshot for Excelsior Biopharma (6496). Check the MyAverix Finance app for the latest dividend data.
What sector is Excelsior Biopharma in?
Excelsior Biopharma (6496) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 6496 listed on?
6496 is listed on TWO.
What is Excelsior Biopharma's net margin?
Excelsior Biopharma (6496) reports a net margin of -19.3% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.